Page last updated: 2024-10-27

fluorouracil and Escherichia coli Infections

fluorouracil has been researched along with Escherichia coli Infections in 7 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Escherichia coli Infections: Infections with bacteria of the species ESCHERICHIA COLI.

Research Excerpts

ExcerptRelevanceReference
" Subsequent dosing with 5-FU induced lethal septicaemia caused by the inoculated strains in most of these mice, whereas CY did not regularly induce septicaemia."1.29Experimental endogenous septicaemia caused by Klebsiella pneumoniae and Escherichia coli in mice. ( Furuya, N; Hirakata, Y; Matsumoto, T; Tateda, K; Yamaguchi, K, 1996)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (85.71)18.2507
2000's1 (14.29)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hirakata, Y1
Furuya, N1
Matsumoto, T1
Tateda, K1
Yamaguchi, K1
Murosaki, S1
Muroyama, K1
Yamamoto, Y1
Kusaka, H1
Liu, T1
Yoshikai, Y4
Nyhlén, A1
Ljungberg, B1
Nilsson-Ehle, I1
Odenholt, I1
Nomoto, K8
Matsuoka, Y1
Hayakawa, K1
Ohwaki, M1
Kan, T1
Yokokura, T3
Mitsuyama, M2

Other Studies

7 other studies available for fluorouracil and Escherichia coli Infections

ArticleYear
Experimental endogenous septicaemia caused by Klebsiella pneumoniae and Escherichia coli in mice.
    Journal of medical microbiology, 1996, Volume: 44, Issue:3

    Topics: Ampicillin; Animals; Bacteremia; Ceftazidime; Cephalosporins; Cyclophosphamide; Disease Models, Anim

1996
Immunopotentiating activity of nigerooligosaccharides for the T helper 1-like immune response in mice.
    Bioscience, biotechnology, and biochemistry, 1999, Volume: 63, Issue:2

    Topics: Animals; Antibodies, Monoclonal; Cells, Cultured; Concanavalin A; Diet; Disaccharides; Enzyme-Linked

1999
Bactericidal effect of combinations of antibiotic and antineoplastic agents against Staphylococcus aureus and Escherichia coli.
    Chemotherapy, 2002, Volume: 48, Issue:2

    Topics: Anti-Bacterial Agents; Antineoplastic Agents; Ceftazidime; Cephalosporins; Doxorubicin; Drug Interac

2002
Antibacterial effect of bovine milk antibody against Escherichia coli in a mouse indigenous infection model.
    Medical microbiology and immunology, 1992, Volume: 181, Issue:2

    Topics: Animals; Antibodies, Bacterial; Cattle; Cecum; Disease Models, Animal; Escherichia coli; Escherichia

1992
Prevention of 5-fluorouracil-induced infection with indigenous Escherichia coli in tumor-bearing mice by nonspecific immunostimulation.
    Canadian journal of microbiology, 1992, Volume: 38, Issue:8

    Topics: Animals; Bacterial Vaccines; Escherichia coli Infections; Fibrosarcoma; Fluorouracil; Lacticaseibaci

1992
Prevention of indigenous infection of mice with Escherichia coli by nonspecific immunostimulation.
    Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:2

    Topics: Adjuvants, Immunologic; Animals; Biological Factors; Escherichia coli Infections; Fluorouracil; Hema

1992
Induction of lethal infection with indigenous Escherichia coli in mice by fluorouracil.
    Canadian journal of microbiology, 1991, Volume: 37, Issue:3

    Topics: Administration, Oral; Animals; Cephalothin; Escherichia coli; Escherichia coli Infections; Fluoroura

1991